The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination of everolimus and lu-177 PRRT in treatment of G1-2 neuroendocrine tumors (NET): Phase 1-2 study.
 
Ali Husain Aljubran
Consulting or Advisory Role - Alcimed
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Merck
 
Mohamed Alrowaili
No Relationships to Disclose
 
Hussein Raef
Consulting or Advisory Role - Novo Nordisk
Research Funding - Novartis (Inst)
 
Shouki Bazarbashi
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Biologix Solutions; Bristol-Myers Squibb; pfizer; Roche
Speakers' Bureau - Lilly
Research Funding - Bayer; Bristol-Myers Squibb; pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; Lilly; Pfizer; Sanofi
 
Ahmed M Alzahrani
Travel, Accommodations, Expenses - Merck
 
Ahmed Almuhaideb
No Relationships to Disclose
 
Hadeel Almanea
No Relationships to Disclose
 
Ahmed ali Badran
No Relationships to Disclose
 
Abdelmuniem Al-Dalee
No Relationships to Disclose
 
Mahmoud Tuli
No Relationships to Disclose